Matthias Bros

4.4k total citations · 1 hit paper
116 papers, 3.0k citations indexed

About

Matthias Bros is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Matthias Bros has authored 116 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 63 papers in Immunology and 15 papers in Oncology. Recurrent topics in Matthias Bros's work include Immunotherapy and Immune Responses (42 papers), RNA Interference and Gene Delivery (33 papers) and Immune Cell Function and Interaction (20 papers). Matthias Bros is often cited by papers focused on Immunotherapy and Immune Responses (42 papers), RNA Interference and Gene Delivery (33 papers) and Immune Cell Function and Interaction (20 papers). Matthias Bros collaborates with scholars based in Germany, United States and Egypt. Matthias Bros's co-authors include Stephan Grabbe, Dominika Hobernik, Lorna Moll, Angelika B. Reske‐Kunz, Henner Stege, Maximilian Haist, Karl Fischer, Matthias Barz, Evelyn Montermann and Holger Frey and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Matthias Bros

112 papers receiving 3.0k citations

Hit Papers

DNA Vaccines—How Far From Clinical Use? 2018 2026 2020 2023 2018 100 200 300

Peers

Matthias Bros
Matthias Bros
Citations per year, relative to Matthias Bros Matthias Bros (= 1×) peers Amir‐Hassan Zarnani

Countries citing papers authored by Matthias Bros

Since Specialization
Citations

This map shows the geographic impact of Matthias Bros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Bros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Bros more than expected).

Fields of papers citing papers by Matthias Bros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Bros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Bros. The network helps show where Matthias Bros may publish in the future.

Co-authorship network of co-authors of Matthias Bros

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Bros. A scholar is included among the top collaborators of Matthias Bros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Bros. Matthias Bros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fichter, Michael, Alexander Fuchs, Paul M. Schneider, et al.. (2025). Unfolding and Degradation of Micellar Immunodrug Carriers Derived From End Group Modified Aliphatic Poly(Carbonate)s with Acid‐Responsive Ketal Side Groups. Advanced Materials. 38(8). e11752–e11752.
2.
Petrosino, Giuseppe, Tina M. Schnöder, Sabine Muth, et al.. (2025). The deacetylases HDAC1/HDAC2 control JAK2V617F-STAT signaling through the ubiquitin ligase SIAH2. Signal Transduction and Targeted Therapy. 10(1). 275–275.
3.
Abdelsalam, Mohamed, Matthias Schmidt, Sara Najafi, et al.. (2025). Identification of a Proteolysis‐Targeting‐Chimera that Addresses Activated Checkpoint Kinase‐1 Reveals its Non‐Catalytic Functions in Tumor Cells. Angewandte Chemie International Edition. 64(49). e202514788–e202514788.
4.
Schulz, Detlef, Barry W. Neun, Edward Cedrone, et al.. (2025). Isomerization of Poly(ethylene glycol): A Strategy for the Evasion of Anti-PEG Antibody Recognition. Journal of the American Chemical Society. 147(25). 21538–21548. 5 indexed citations
5.
Tubbe, Ingrid, et al.. (2025). The RNA-binding protein KSRP reduces asthma-like characteristics in a murine model. Inflammation Research. 74(1). 54–54.
6.
Fuchs, Alexander, Konrad Maxeiner, Pia Winterwerber, et al.. (2024). Introducing Degradable Cationic Nanogels Carrying TLR9 Stimulating Oligonucleotides. Small. 21(4). e2406082–e2406082. 2 indexed citations
7.
Schneider, Paul M., Michael Fichter, Federica De Lorenzi, et al.. (2024). A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing. Pharmacological Research. 211. 107560–107560. 2 indexed citations
8.
Abdelsalam, Mohamed, Caroline Alvares, Matthias Schmidt, et al.. (2024). Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins. Leukemia. 38(12). 2561–2572. 12 indexed citations
9.
Radsak, Markus P., et al.. (2024). Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Molecular Oncology. 18(8). 1958–1965. 2 indexed citations
10.
Schneider, Paul M., Hua Zhang, Ömer Öztürk, et al.. (2023). In vivo gene silencing with novel siRNA loaded polypeptoide nanoparticles for anti-stromal therapy in hepatocellular carcinoma. Zeitschrift für Gastroenterologie. 61(8). e492–e493. 1 indexed citations
11.
Beyer, Mandy, Hany S. Ibrahim, Walburgis Brenner, et al.. (2023). Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3. Leukemia. 37(11). 2319–2323. 6 indexed citations
12.
Kaps, Leonard, Paul M. Schneider, Maximiliano L. Cacicedo, et al.. (2023). Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications. International Journal of Molecular Sciences. 24(14). 11869–11869. 7 indexed citations
14.
Raker, Verena, Detlef Becker, Matthias Bros, et al.. (2022). Protease‐ and cell type–specific activation of protease‐activated receptor 2 in cutaneous inflammation. Journal of Thrombosis and Haemostasis. 20(12). 2823–2836. 8 indexed citations
15.
Haist, Maximilian, et al.. (2021). Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond. International Journal of Molecular Sciences. 22(18). 9890–9890. 17 indexed citations
16.
Moll, Lorna, et al.. (2018). Interleukin-1 Beta—A Friend or Foe in Malignancies?. International Journal of Molecular Sciences. 19(8). 2155–2155. 333 indexed citations
17.
Birke, Alexander, David Huesmann, Benjamin Weber, et al.. (2014). Introducing PeptoPlexes: Polylysine‐block‐Polysarcosine Based Polyplexes for Transfection of HEK 293T Cells. Macromolecular Bioscience. 14(10). 1380–1395. 71 indexed citations
18.
Fischer, Karl, Kaloian Koynov, Matthias Bros, et al.. (2014). Selective Uptake of Cylindrical Poly(2‐Oxazoline) Brush‐AntiDEC205 Antibody‐OVA Antigen Conjugates into DEC‐Positive Dendritic Cells and Subsequent T‐Cell Activation. Chemistry - A European Journal. 20(39). 12405–12410. 39 indexed citations
19.
Boissel, Jean‐Paul, et al.. (2004). The Neuronal Nitric Oxide Synthase Is Upregulated in Mouse Skin Repair and in Response to Epidermal Growth Factor in Human HaCaT Keratinocytes. Journal of Investigative Dermatology. 123(1). 132–139. 36 indexed citations
20.
Bros, Matthias, et al.. (2003). The Human Fascin Gene Promoter Is Highly Active in Mature Dendritic Cells Due to a Stage-Specific Enhancer. The Journal of Immunology. 171(4). 1825–1834. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026